← Back to Screener
RadNet, Inc. Common Stock (RDNT)
Price$60.39
Favorite Metrics
Price vs S&P 500 (26W)-23.21%
Price vs S&P 500 (4W)-11.28%
Market Capitalization$4.69B
P/E Ratio (Annual)1779.27x
All Metrics
P/CF (Annual)15.69x
Book Value / Share (Quarterly)$14.72
P/TBV (Annual)5.86x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)12.57%
Cash Flow / Share (Quarterly)$1.16
Price vs S&P 500 (YTD)-19.50%
Gross Margin (TTM)19.68%
Net Profit Margin (TTM)-0.91%
EPS (TTM)$-0.26
10-Day Avg Trading Volume0.77M
EPS Excl Extra (TTM)$-0.26
Revenue Growth (5Y)13.74%
EPS (Annual)$-0.25
ROI (Annual)-0.86%
Gross Margin (Annual)21.11%
Net Profit Margin (5Y Avg)0.41%
Cash / Share (Quarterly)$10.36
Revenue Growth QoQ (YoY)14.80%
EPS Growth (5Y)-33.83%
P/E Normalized (Annual)1779.27x
ROA (Last FY)-0.50%
Revenue Growth TTM (YoY)11.51%
EBITD / Share (TTM)$3.24
ROE (5Y Avg)2.62%
Operating Margin (TTM)3.04%
Cash Flow / Share (Annual)$1.16
P/B Ratio4.30x
P/B Ratio (Quarterly)5.06x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.46x
Net Interest Coverage (TTM)1.51x
ROA (TTM)-0.52%
EPS Growth QoQ (YoY)63.93%
EV / EBITDA (TTM)20.35x
EPS Incl Extra (Annual)$-0.25
Current Ratio (Annual)1.76x
Quick Ratio (Quarterly)1.67x
3-Month Avg Trading Volume0.86M
52-Week Price Return19.54%
EV / Free Cash Flow (Annual)58.55x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$12.71
P/S Ratio (Annual)2.30x
Asset Turnover (Annual)0.54x
52-Week High$85.84
Operating Margin (5Y Avg)4.64%
EPS Excl Extra (Annual)$-0.25
CapEx CAGR (5Y)17.75%
Tangible BV CAGR (5Y)52.70%
26-Week Price Return-14.46%
Quick Ratio (Annual)1.67x
13-Week Price Return-17.16%
Total Debt / Equity (Annual)1.00x
Current Ratio (Quarterly)1.76x
Enterprise Value$5,009.7
Revenue / Share Growth (5Y)5.20%
Asset Turnover (TTM)0.57x
Book Value / Share Growth (5Y)34.89%
Revenue / Employee (Annual)$0
Pretax Margin (Annual)1.56%
Cash / Share (Annual)$10.36
3-Month Return Std Dev47.43%
Gross Margin (5Y Avg)22.08%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)14.26%
EBITDA Interim CAGR (5Y)10.20%
ROE (Last FY)-1.71%
Net Interest Coverage (Annual)1.51x
EPS Basic Excl Extra (Annual)$-0.25
P/FCF (TTM)46.62x
Receivables Turnover (TTM)9.26x
EV / Free Cash Flow (TTM)58.55x
Total Debt / Equity (Quarterly)1.00x
EPS Incl Extra (TTM)$-0.26
Receivables Turnover (Annual)9.26x
ROI (TTM)-0.90%
P/S Ratio (TTM)2.30x
Pretax Margin (5Y Avg)2.78%
Revenue / Share (Annual)$27.13
Tangible BV / Share (Annual)$12.71
Forward P/E96.37x
Free OCF CAGR (5Y)-9.33%
Price vs S&P 500 (52W)-15.56%
Year-to-Date Return-15.36%
5-Day Price Return7.40%
EPS Normalized (Annual)$-0.25
ROA (5Y Avg)0.27%
Net Profit Margin (Annual)-0.91%
Month-to-Date Return8.05%
Cash Flow / Share (TTM)$2.55
EBITD / Share (Annual)$3.27
EPS Growth (3Y)-56.76%
Operating Margin (Annual)3.04%
LT Debt / Equity (Annual)0.98x
P/CF (TTM)15.69x
ROI (5Y Avg)0.58%
LT Debt / Equity (Quarterly)0.98x
EPS Basic Excl Extra (TTM)$-0.26
P/TBV (Quarterly)5.86x
P/B Ratio (Annual)5.06x
Pretax Margin (TTM)1.56%
Book Value / Share (Annual)$14.72
Price vs S&P 500 (13W)-20.03%
Net Margin Growth (5Y)-34.87%
Beta1.53x
P/FCF (Annual)54.77x
Revenue / Share (TTM)$26.62
ROE (TTM)-1.88%
52-Week Low$46.76
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.31
4.29
4.29
4.29
Industry Peers — Health Services(20)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
RDNTRadNet, Inc. Common Stock | 1779.27x | 11.51% | 3.04% | -1.88% | $60.39 |
NTRANatera, Inc. Common Stock | — | 35.90% | -13.44% | -15.28% | $208.40 |
LHLabcorp Holdings Inc. | 25.45x | 7.25% | 9.92% | 10.28% | $270.68 |
DGXQuest Diagnostics Inc. | 21.60x | 11.78% | 14.10% | 13.88% | $195.02 |
EXASExact Sciences Corp | — | 17.69% | -6.35% | -8.51% | $104.91 |
GHGuardant Health, Inc. Common Stock | — | 32.88% | -45.02% | -246.60% | $90.36 |
VCYTVeracyte, Inc. | 40.48x | 16.01% | 11.17% | 5.33% | $33.80 |
GRALGRAIL, Inc. Common Stock | — | 17.18% | -381.98% | -17.11% | $51.71 |
CDNACareDx, Inc. | 18.34x | 13.79% | -8.10% | -6.47% | $21.42 |
FTREFortrea Holdings Inc. Common Stock | — | 1.00% | -32.04% | -152.17% | $10.38 |
CSTLCastle Biosciences, Inc. Common Stock | 47.31x | 3.66% | -12.44% | -5.27% | $25.05 |
About
RadNet Inc operates a national network of diagnostic imaging centers offering MRI, CT, PET, nuclear medicine, mammography, and other imaging services. The company's Digital Health segment develops clinical applications for medical image interpretation and patient outcomes, with specialized focus on brain, breast, prostate, and pulmonary diagnostics.